Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Psychoanalysis Meets LSD: Argentina's Lost 1950s Era Of Psychedelic Therapy
Tickers NEWS
Tags Argentine Psychoanalytic Association Benzinga Psychology
From Benzinga
Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead
Tickers MDMA NEWS
Tags Benzinga the hill News
From Benzinga
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Tickers IIPR MDMA
Tags Rick Doblin MDMA IIPR
From Benzinga
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Tickers AWKNF BETRF CMND FLHLF
Tags Benzinga TRUFF Psychedelics
From Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
Tickers NEWS NUMIF
Tags News Psychedelics Research Psychedelics
From Benzinga
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute
Tickers NEWS OPTHF
Tags Psilocybin program Psychedelics Research Psychedelics
From Benzinga
Psychedelics Reform Update: Missouri's $10M Budget, Maine's & Maryland's Study Groups, Oregon's Re-Crim And More
Tags Management Legal Benzinga
From Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Tickers CMND CMPS CYBN FLHLF
Tags News CMND Market News
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Tickers ATAI CMPS
Tags Psychedelic/Assisted Therapies Cannabis ATAI
From Benzinga
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Tickers ATAI NEWS
Tags News treatment/resistant depression 5/MeO/DMT
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
Tickers MNMD NEWS
Tags Psychedelics Benzinga Interview
From Benzinga
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Tickers ATAI CMND CMPS CYBN
Tags GHRS SILO Psychedelics Research
From Benzinga
Psychedelics Update: Task Forces In Three States, Decrim No-Go, Arizona Psilocybin Centers, Utah And More
Tags Management Legal Benzinga
From Benzinga
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Tickers ATAI BETRF CMND ENVB
Tags Global Psychedelic/Assisted Therapies Market News
From Benzinga
Fed Agency Grants $14M To Gilgamesh For Cardiac-Safe Ibogaine Analog Targeting Opioid Use Disorder
Tickers NEWS
Tags Gilgamesh Pharmaceuticals Psychedelic/Assisted Therapies Market News
From Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Tickers CMPS CYBN MNMD
Tags Biotech Benzinga Psychedelics
From Benzinga
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
Tickers PBM
Tags Palliative Care PBM Management
From Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
Tickers MNMD NEWS
Tags Management Financing MNMD
From Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
Tickers CMPS MNMD NEWS
Tags Benzinga Psychedelics Generalized Anxiety Disorder
From Benzinga
Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More
Tickers BWVI CMPS IBOGF
Tags Psychedelics Benzinga Biotech
From Benzinga
Psychedelics Reform Update: Connecticut's Decriminalization, Vermont Hearings, Arizona's Psilocybin Services & More
Tags Psychedelics Reform Psychedelics Benzinga
From Benzinga
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Tickers BRAXF FLHLF OPTHF SILFF
Tags Legal Management OPTHF
From Benzinga
GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates
Tickers GHRS NEWS
Tags Benzinga Psychedelics GHRS
From Benzinga
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment
Tickers CMPS
Tags Cannabis CMPS Market News
From Benzinga
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
Tickers BRAXF BWVI CMPS NEWS
Tags Interview Top Stories Benzinga
From Benzinga
Beckley Academy's Open-Source Psychedelic Therapy Learning Framework Is Out: What's It All About? Authoring Team Shares Insights
Tags American Psychedelic Practitioners Association Psychedelic/Assisted Therapies Market News
From Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
Tickers MNMD
Tags LSD Therapy 2023 financial results Biotech
From Benzinga
LSD Microdosing For Depression? This Clinical Study Reveals Promising Results
Tickers NEWS
Tags major depressive disorder Management At/Home Therapy
From Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Tickers ATAI AWKNF CMND CYBN
Tags CYBN Psychedelic/Assisted Therapies Cannabis
From Benzinga
Medford Massachusets Move To Decriminalize Psychedelics Has Statewide Reform Implications
Tags Psychedelic/Assisted Therapies Market News Cannabis
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.